APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

Arcus Biosciences, Inc. (NASDAQ:NYSE:RCUS), a biotechnology company focused on developing innovative cancer therapies, is navigating a critical phase in its development pipeline. With several key ...

A polypill for preventing cardiovascular disease has the potential to address health inequities and expand health care access ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...